129 results on '"Islander, Ulrika"'
Search Results
2. Role of estrogen signaling in fibroblastic reticular cells for innate and adaptive immune responses in antigen‐induced arthritis.
- Author
-
Barrett, Aidan, Horkeby, Karin, Corciulo, Carmen, Carlsten, Hans, Lagerquist, Marie K, Scheffler, Julia M, and Islander, Ulrika
- Subjects
RHEUMATOID arthritis ,KNOCKOUT mice ,STROMAL cells ,CELL populations ,LYMPH nodes ,ESTROGEN receptors - Abstract
Women are more prone to develop rheumatoid arthritis, with peak incidence occurring around menopause. Estrogen has major effects on the immune system and is protective against arthritis. We have previously shown that treatment with estrogen inhibits inflammation and joint destruction in murine models of arthritis, although the mechanisms involved remain unclear. Fibroblastic reticular cells (FRCs) are specialized stromal cells that generate the three‐dimensional structure of lymph nodes (LNs). FRCs are vital for coordinating immune responses from within LNs and are characterized by the expression of the chemokine CCL19, which attracts immune cells. The aim of this study was to determine whether the influence of estrogen on innate and adaptive immune cells in arthritis is mediated by estrogen signaling in FRCs. Conditional knockout mice lacking estrogen receptor α (ERα) in CCL19‐expressing cells (Ccl19‐CreERαfl/fl) were generated and tested. Ccl19‐CreERαfl/fl mice and littermate controls were ovariectomized, treated with vehicle or estradiol and subjected to the 28‐day‐long antigen‐induced arthritis model to enable analyses of differentiated T‐ and B‐cell populations and innate cells in LNs by flow cytometry. The results reveal that while the response to estradiol treatment in numbers of FRCs per LN is significantly reduced in mice lacking ERα in FRCs, estrogen does not inhibit joint inflammation or markedly affect immune responses in this arthritis model. Thus, this study validates the Ccl19‐CreERαfl/fl strain for studying estrogen signaling in FRCs within inflammatory diseases, although the chosen arthritis model is deemed unsuitable for addressing this question. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. The Pseudomonas aeruginosa lectin LecB modulates intracellular reactive oxygen species production in human neutrophils.
- Author
-
Sanchez Klose, Felix P., Dahlstrand Rudin, Agnes, Bergqvist, Linda, Scheffler, Julia M., Jönsson, Katarina, Islander, Ulrika, Karlsson‐Bengtsson, Anna, Bylund, Johan, and Venkatakrishnan, Vignesh
- Subjects
REACTIVE oxygen species ,QUORUM sensing ,PSEUDOMONAS aeruginosa ,RHAMNOLIPIDS ,NEUTROPHILS ,LECTINS ,CELL membranes ,BACTERIAL cell surfaces - Abstract
Pseudomonas aeruginosa is a Gram‐negative bacterium and an opportunistic pathogen ubiquitously present throughout nature. LecB, a fucose‐, and mannose‐binding lectin, is a prominent virulence factor of P. aeruginosa, which can be expressed on the bacterial surface but also be secreted. However, the LecB interaction with human immune cells remains to be characterized. Neutrophils comprise the first line of defense against infections and their production of reactive oxygen species (ROS) and release of extracellular traps (NETs) are critical antimicrobial mechanisms. When profiling the neutrophil glycome we found several glycoconjugates on granule and plasma membranes that could potentially act as LecB receptors. In line with this, we here show that soluble LecB can activate primed neutrophils to produce high levels of intracellular ROS (icROS), an effect that was inhibited by methyl fucoside. On the other hand, soluble LecB inhibits P. aeruginosa‐induced icROS production. In support of that, during phagocytosis of wild‐type and LecB‐deficient P. aeruginosa, bacteria with LecB induced less icROS production as compared with bacteria lacking the lectin. Hence, LecB can either induce or inhibit icROS production in neutrophils depending on the circumstances, demonstrating a novel and potential role for LecB as an immunomodulator of neutrophil functional responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Effects of a tissue-selective estrogen complex on B lymphopoiesis and B cell function
- Author
-
Nordqvist, Jauquline, Bernardi, Angelina, Islander, Ulrika, and Carlsten, Hans
- Published
- 2017
- Full Text
- View/download PDF
5. Ovarian hormones in innate inflammation
- Author
-
Stubelius, Alexandra, Andersson, Annica, Islander, Ulrika, and Carlsten, Hans
- Published
- 2017
- Full Text
- View/download PDF
6. Sex and gender in infection and immunity: addressing the bottlenecks from basic science to public health and clinical applications
- Author
-
Pasin, Chloé, Consiglio, Camila R, Huisman, Jana S, de Lange, Ann-Marie G, Peckham, Hannah, Vallejo-Yagüe, Enriqueta, Abela, Irene A, Islander, Ulrika, Neuner-Jehle, Nadia, Pujantell, Maria, Roth, Olivia, Schirmer, Melanie, Tepekule, Burcu, Zeeb, Marius, Hachfeld, Anna, Aebi-Popp, Karoline, Kouyos, Roger D, and Bonhoeffer, Sebastian
- Subjects
sex and gender ,infection ,immunity ,bottlenecks ,610 Medicine & health - Abstract
Although sex and gender are recognized as major determinants of health and immunity, their role is rarely considered in clinical practice and public health. We identified six bottlenecks preventing the inclusion of sex and gender considerations from basic science to clinical practice, precision medicine and public health policies. (i) A terminology-related bottleneck, linked to the definitions of sex and gender themselves, and the lack of consensus on how to evaluate gender. (ii) A data-related bottleneck, due to gaps in sex-disaggregated data, data on trans/non-binary people and gender identity. (iii) A translational bottleneck, limited by animal models and the underrepresentation of gender minorities in biomedical studies. (iv) A statistical bottleneck, with inappropriate statistical analyses and results interpretation. (v) An ethical bottleneck posed by the underrepresentation of pregnant people and gender minorities in clinical studies. (vi) A structural bottleneck, as systemic bias and discriminations affect not only academic research but also decision makers. We specify guidelines for researchers, scientific journals, funding agencies and academic institutions to address these bottlenecks. Following such guidelines will support the development of more efficient and equitable care strategies for all., Royal Society Open Science, 10 (7), ISSN:2054-5703
- Published
- 2023
- Full Text
- View/download PDF
7. IL-17-producing γδT cells are regulated by estrogen during development of experimental arthritis
- Author
-
Andersson, Annica, Grahnemo, Louise, Engdahl, Cecilia, Stubelius, Alexandra, Lagerquist, Marie K., Carlsten, Hans, and Islander, Ulrika
- Published
- 2015
- Full Text
- View/download PDF
8. Selective estrogen receptor modulators in T cell development and T cell dependent inflammation
- Author
-
Bernardi, Angelina I., Andersson, Annica, Stubelius, Alexandra, Grahnemo, Louise, Carlsten, Hans, and Islander, Ulrika
- Published
- 2015
- Full Text
- View/download PDF
9. Profiling of innate and adaptive immune cells during influenza virus infection reveals sex bias in invariant natural killer T (iNKT) cells.
- Author
-
Humeniuk, Piotr, Barrett, Aidan, Axelsson, Hannes, Corciulo, Carmen, Drevinge, Christina, Pons, Alicia Del Carpio, Angeletti, Davide, Scheffler, Julia M., and Islander, Ulrika
- Subjects
VIRUS diseases ,INFLUENZA A virus ,INFLUENZA viruses ,IMMUNOMODULATORS ,SEX (Biology) - Abstract
Background: Influenza A virus (IAV) infection leads to significant morbidity and mortality. Biological sex influences the immune responses to IAV infection, resulting in higher mortality in women of reproductive age. Previous studies revealed increased activation of T and B cells in female mice after IAV infection, but extensive analysis of sex differences in both innate and adaptive immune cells over time is lacking. Invariant natural killer T (iNKT) cells are fast‐reacting forces and modulators of immune responses that are important to IAV immunity, but it is not known if the presence and function of iNKT cells differ between females and males. The aim of this study was to determine immunological mechanisms that contribute to the increased disease severity in female mice during IAV infection. Methods: Female and male mice were infected with mouse‐adapted IAV and monitored for weight loss and survival. Immune cell populations and cytokine expression in bronchoalveolar lavage fluid, lung, and mediastinal lymph node were determined at three time points after infection using flow cytometry and ELISA. Results: The results reveal increased severity and mortality in adult female mice compared to age‐matched males. Female mice show larger increases in innate and adaptive immune cell populations and cytokine production in lung compared to mock on Day 6 postinfection. On Day 9 postinfection, female mice express higher numbers of iNKT cells in lung and liver compared to males. Conclusions: This comprehensive analysis of immune cells and cytokines over time following IAV infection reveals increased leukocyte expansion and stronger proinflammatory cytokine responses in female mice during disease initiation. Furthermore, this is the first study to report a sex bias in iNKT cell populations after IAV infection. The data suggests that the process of recovery from IAV‐induced airway inflammation is associated with increased expansion of several different iNKT cell subpopulations in female mice. Highlights: Infection with influenza A virus (IAV) leads to increased weight loss and mortality in female mice.IAV infection induces increased leukocyte expansion and stronger proinflammatory cytokine responses in the lung of female mice compared to mock on Day 6 postinfection.IAV infection leads to a sex‐specific increase of invariant natural killer T (iNKT) cell populations in lung and liver of female mice on Day 9 postinfection.The association between weight gain and the sex‐specific increase in iNKT cells on Day 9 postinfection implicate a role for iNKT cells in the resolution of inflammation in female mice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Sexual dimorphisms in the immune system of catechol-O-methyltransferase knockout mice
- Author
-
Stubelius, Alexandra, Wilhelmson, Anna S., Gogos, Joseph A., Tivesten, Åsa, Islander, Ulrika, and Carlsten, Hans
- Published
- 2012
- Full Text
- View/download PDF
11. Ethanol Prevents Development of Destructive Arthritis
- Author
-
Jonsson, Ing-Marie, Verdrengh, Margareta, Brisslert, Mikael, Lindblad, Sofia, Bokarewa, Maria, Islander, Ulrika, Carlsten, Hans, Ohlsson, Claes, Nandakumar, Kutty Selva, Holmdahl, Rikard, and Tarkowski, Andrej
- Published
- 2007
- Full Text
- View/download PDF
12. Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis
- Author
-
Andersson, Annica, Bernardi, Angelina I., Stubelius, Alexandra, Nurkkala-Karlsson, Merja, Ohlsson, Claes, Carlsten, Hans, and Islander, Ulrika
- Published
- 2016
- Full Text
- View/download PDF
13. Suppression of Experimental Arthritis and Associated Bone Loss by a Tissue-Selective Estrogen Complex
- Author
-
Andersson, Annica, Bernardi, Angelina I., Nurkkala-Karlsson, Merja, Stubelius, Alexandra, Grahnemo, Louise, Ohlsson, Claes, Carlsten, Hans, and Islander, Ulrika
- Published
- 2016
14. Enzalutamide Reduces the Bone Mass in the Axial But Not the Appendicular Skeleton in Male Mice
- Author
-
Wu, Jianyao, Movérare-Skrtic, Sofia, Börjesson, Anna E., Lagerquist, Marie K., Sjögren, Klara, Windahl, Sara H., Koskela, Antti, Grahnemo, Louise, Islander, Ulrika, Wilhelmson, Anna S., Tivesten, Åsa, Tuukkanen, Juha, and Ohlsson, Claes
- Published
- 2016
15. Physiological levels of estradiol limit murine osteoarthritis progression.
- Author
-
Corciulo, Carmen, Scheffler, Julia M., Humeniuk, Piotr, Del Carpio Pons, Alicia, Stubelius, Alexandra, Von Mentzer, Ula, Drevinge, Christina, Barrett, Aidan, Wüstenhagen, Sofia, Poutanen, Matti, Ohlsson, Claes, Lagerquist, Marie K., and Islander, Ulrika
- Subjects
BONE density ,ESTRADIOL ,CANCELLOUS bone ,OSTEOARTHRITIS ,KNEE osteoarthritis ,KNEE pain ,GROIN pain ,INDUCED ovulation - Abstract
Among patients with knee osteoarthritis (OA), postmenopausal women are over-represented. The purpose of this study was to determine whether deficiency of female sex steroids affects OA progression and to evaluate the protective effect of treatment with a physiological dose of 17β-estradiol (E2) on OA progression using a murine model. Ovariectomy (OVX) of female mice was used to mimic a postmenopausal state. OVX or sham-operated mice underwent surgery for destabilization of the medial meniscus (DMM) to induce OA. E2 was administered in a pulsed manner for 2 and 8 weeks. OVX of OA mice did not influence the cartilage phenotype or synovial thickness, while both cortical and trabecular subchondral bone mineral density (BMD) decreased after OVX compared with sham-operated mice at 8 weeks post-DMM surgery. Additionally, OVX mice displayed decreased motor activity, reduced threshold of pain sensitivity, and increased number of T cells in the inguinal lymph nodes compared to sham-operated mice 2 weeks after OA induction. Eight weeks of treatment with E2 prevented cartilage damage and thickening of the synovium in OVX OA mice. The motor activity was improved after E2 replacement at the 2 weeks time point, which was also associated with lower pain sensitivity in the OA paw. E2 treatment protected against OVX-induced loss of subchondral trabecular bone. The number of T cells in the inguinal lymph nodes was reduced by E2 treatment after 8 weeks. This study demonstrates that treatment with a physiological dose of E2 exerts a protective role by reducing OA symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Reduction of Mature B Cells and Immunoglobulins Results in Increased Trabecular Bone.
- Author
-
Lagerquist, Marie K., Gupta, Priti, Sehic, Edina, Horkeby, Karin L., Scheffler, Julia M., Nordqvist, Jauquline, Lawenius, Lina, Islander, Ulrika, Corciulo, Carmen, Henning, Petra, Carlsten, Hans, and Engdahl, Cecilia
- Subjects
CANCELLOUS bone ,IMMUNOGLOBULINS ,B cells ,BONE resorption ,OSTEOCLASTS ,BONE remodeling ,OSTEOPROTEGERIN ,AUTOANTIBODIES - Abstract
Inflammation has a significant effect on bone remodeling and can result in bone loss via increased stimulation of osteoclasts. Activated immunoglobulins, especially autoantibodies, can increase osteoclastogenesis and are associated with pathological bone loss. Whether immunoglobulins and mature B lymphocytes are important for general bone architecture has not been completely determined. Here we demonstrate, using a transgenic mouse model, that reduction of mature B cells and immunoglobulins leads to increased trabecular bone mass compared to wild‐type (WT) littermate controls. This bone effect is associated with a decrease in the number of osteoclasts and reduced bone resorption, despite decreased expression of osteoprotegerin. We also demonstrate that the reduction of mature B cells and immunoglobulins do not prevent bone loss caused by estrogen deficiency or arthritis compared to WT littermate controls. In conclusion, the reduction of mature B cells and immunoglobulins results in disturbed regulation of trabecular bone turnover in healthy conditions but is dispensable for pathological bone loss. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. ERα Signaling in a Subset of CXCL12‐Abundant Reticular Cells Regulates Trabecular Bone in Mice.
- Author
-
Scheffler, Julia M, Gustafsson, Karin L, Barrett, Aidan, Corciulo, Carmen, Drevinge, Christina, Del Carpio Pons, Alicia M, Humeniuk, Piotr, Engdahl, Cecilia, Gustafsson, Jan‐Åke, Ohlsson, Claes, Carlsten, Hans, Lagerquist, Marie K., and Islander, Ulrika
- Subjects
CANCELLOUS bone ,MESENCHYMAL stem cells ,BONE health ,BONE density ,STROMAL cell-derived factor 1 ,OSTEOCLASTOGENESIS ,HOMEOSTASIS - Abstract
Estrogen has pronounced effects on the immune system, which also influences bone homeostasis. In recent years, stromal cells in lymphoid organs have gained increasing attention as they not only support the regulation of immune responses but also affect bone remodeling. A conditional knockout mouse model where estrogen receptor alpha (ERα) is deleted in CCL19‐expressing stromal cells (Ccl19‐Cre ERαfl/fl mice) was generated and bone densitometry was performed to analyze the importance of stromal cell–specific ERα signaling on the skeleton. Results showed that female Ccl19‐Cre ERαfl/fl mice display reduced total bone mineral density and detailed X‐ray analyses revealed that ERα expression in CCL19‐expressing stromal cells is important for trabecular but not cortical bone homeostasis. Further analysis showed that the trabecular bone loss is caused by increased osteoclastogenesis. Additionally, the bone formation rate was reduced; however, the expression of osteoprogenitor genes was not altered. Analysis of the bone marrow stromal cell compartment revealed a deletion of ERα in a subgroup of CXCL12‐abundant reticular (CAR) cells resulting in increased secretion of the pro‐osteoclastogenic chemokine CXCL12. In conclusion, this study reveals the importance of ERα signaling in CAR cells for bone health. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. A tissue-specific role of membrane-initiated ERα signaling for the effects of SERMs.
- Author
-
Gustafsson, Karin L., Movérare-Skrtic, Sofia, Farman, Helen H., Engdahl, Cecilia, Henning, Petra, Nilsson, Karin H., Scheffler, Julia M., Sehic, Edina, Islander, Ulrika, Levin, Ellis, Ohlsson, Claes, and Lagerquist, Marie K.
- Subjects
SELECTIVE estrogen receptor modulators ,ADIPOSE tissues ,COMPACT bone ,CANCELLOUS bone ,FAT - Abstract
Selective estrogen receptor modulators (SERMs) act as estrogen receptor (ER) agonists or antagonists in a tissue-specific manner. ERs exert effects via nuclear actions but can also utilize membrane-initiated signaling pathways. To determine if membraneinitiated ERα (mERα) signaling affects SERM action in a tissue-specific manner, C451A mice, lacking mERα signaling due to a mutation at palmitoylation site C451, were treated with Lasofoxifene (Las), Bazedoxifene (Bza), or estradiol (E2), and various tissues were evaluated. Las and Bza treatment increased uterine weight to a similar extent in C451A and control mice, demonstrating mERα-independent uterine SERM effects, while the E2 effect on the uterus was predominantly mERα-dependent. Las and Bza treatment increased both trabecular and cortical bone mass in controls to a similar degree as E2, while both SERM and E2 treatment effects were absent in C451A mice. This demonstrates that SERM effects, similar to E2 effects, in the skeleton are mERαdependent. Both Las and E2 treatment decreased thymus weight in controls, while neither treatment affected the thymus in C451A mice, demonstrating mERα-dependent SERM and E2 effects in this tissue. Interestingly, both SERM and E2 treatments decreased the total body fat percent in C451A mice, demonstrating the ability of these treatments to affect fat tissue in the absence of functional mERα signaling. In conclusion, mERα signaling can modulate SERM responses in a tissue-specific manner. This novel knowledge increases the understanding of the mechanisms behind SERM effects and may thereby facilitate the development of new improved SERMs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. A tissue-selective estrogen complex as treatment of osteoporosis in experimental lupus.
- Author
-
Nordqvist, Jauquline, Engdahl, Cecilia, Scheffler, Julia M, Gupta, Priti, Gustafsson, Karin L, Lagerquist, Marie K, Carlsten, Hans, and Islander, Ulrika
- Subjects
SYSTEMIC lupus erythematosus ,OSTEOPOROSIS ,SELECTIVE estrogen receptor modulators ,DUAL-energy X-ray absorptiometry ,OSTEOPOROSIS in women ,CANCELLOUS bone ,ESTROGEN - Abstract
Osteoporosis is a common secondary complication in patients with systemic lupus erythematosus (SLE). Current osteoporosis treatment with bisphosphonates has some negative side effects and there is a lack of data regarding newer treatments options for SLE associated osteoporosis. The tissue-selective estrogen complex (TSEC) containing conjugated estrogens and the selective estrogen receptor modulator bazedoxifene (Bza) is approved for treatment of postmenopausal vasomotor symptoms and prevention of osteoporosis. However, it has not been evaluated for treatment of osteoporosis in postmenopausal SLE patients. Ovariectomized MRL/ lpr mice constitute a model for postmenopausal lupus that can be used for osteoporosis studies. We used this model in a set of experiments where the mice were treated with different doses of 17β-estradiol-3-benzoate (E2), Bza, or TSEC (E2 plus Bza), administered in the early or late phases of disease development. The skeleton was analyzed by dual-energy X-ray absorptiometry, peripheral quantitative computed tomography, and high-resolution microcomputed tomography. The lupus disease was assessed by determination of proteinuria, hematuria, and lupus disease markers in serum. Treatment with medium dose TSEC administered in early disease protected ovariectomized MRL/ lpr mice from trabecular bone loss, while there were no differences in lupus disease parameters between treatments. This is the first experimental study to investigate TSEC as a potential new therapy for osteoporosis in postmenopausal SLE. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Estrogen receptor α (ERα) expression in cartilage is important for the ameliorating effects of estrogen on synovitis, but not joint destruction.
- Author
-
Engdahl, Cecilia, Börjesson, Anna E, Andersson, Annica, Stubelius, Alexandra, Krust, Andree, Chambon, Pierre, Islander, Ulrika, Ohlsson, Claes, Carlsten, Hans, and Lagerquist, Marie K
- Published
- 2012
- Full Text
- View/download PDF
21. Modulation of IL-17 producing cells in estrogen-mediated inhibition of experimental arthritis
- Author
-
Andersson, Annica, Stubelius, Alexandra, Erlandsson, Malin, Carlsten, Hans, and Islander, Ulrika
- Published
- 2012
- Full Text
- View/download PDF
22. Galectin 3 as a novel therapeutic target in rheumatoid arthritis: Comment on the article by Forsman et al
- Author
-
Forsman, Huamei, Islander, Ulrika, and Karlsson, Anna
- Published
- 2011
- Full Text
- View/download PDF
23. Galectin 3 Aggravates Joint Inflammation and Destruction in Antigen-Induced Arthritis
- Author
-
Forsman, Huamei, Islander, Ulrika, Andréasson, Emil, Andersson, Annica, Önnheim, Karin, Karlström, Alexandra, Sävman, Karin, Magnusson, Mattias, Brown, Kelly L., and Karlsson, Anna
- Published
- 2011
- Full Text
- View/download PDF
24. Role of Raloxifene As A Potent inhibitor of Experimental Postmenopausal Polyarthritis and Osteoporosis
- Author
-
Jochems, Caroline, Islander, Ulrika, Kallkopf, Anna, Lagerquist, Marie, Ohlsson, Claes, and Carlsten, Hans
- Published
- 2007
25. Intermediate monocytes correlate with CXCR3+ Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis.
- Author
-
Drevinge, Christina, Scheffler, Julia M, Koro-Arvidsson, Catalin, Sundh, Daniel, Carlsten, Hans, Gjertsson, Inger, Lindholm, Catharina, Lorentzon, Mattias, Rudin, Anna, Ekwall, Anna-Karin Hultgård, and Islander, Ulrika
- Subjects
T helper cells ,MONOCYTES ,RHEUMATOID arthritis ,BONE densitometry ,SUPPRESSOR cells ,BONE density - Abstract
Background: Rheumatoid arthritis (RA) is associated with development of generalized osteoporosis. Bone-degrading osteoclasts are derived from circulating precursor cells of monocytic lineage, and the intermediate monocyte population is important as osteoclast precursors in inflammatory conditions. T cells of various subsets are critical in the pathogenesis of both RA and associated osteoporosis, but so far, no studies have examined associations between circulating intermediate monocytes, T cell subsets and bone characteristics in patients with RA. The aim of this study was to investigate the frequency of intermediate monocytes in patients with untreated early rheumatoid arthritis (ueRA) compared to healthy controls (HC), and to explore the correlation between intermediate monocytes and a comprehensive panel of T helper cell subsets, bone density and bone microarchitecture in ueRA patients. Methods: 78 patients with ueRA fulfilling the ACR/EULAR 2010 criteria were included and compared to 29 age- and sex-matched HC. Peripheral blood samples were obtained before start of treatment and proportions of monocyte subsets and CD4
+ helper and regulatory T cell subsets were analyzed by flow cytometry. Bone densitometry was performed on 46 of the ueRA patients at inclusion using DXA and HR-pQCT. Results: Flow cytometric analyses showed that the majority of ueRA patients had frequencies of intermediate monocytes comparable to HC. The intermediate monocyte population correlated positively with CXCR3+ Th17 cells in ueRA patients but not in HC. However, neither the proportions of intermediate monocytes nor CXCR3+ Th17 cells were associated with bone density or bone microarchitecture measurements. Conclusions: Our findings suggest that in early RA, the intermediate monocytes do not correlate with bone characteristics, despite positive correlation with circulating CXCR3+ Th17 cells. Future longitudinal studies in patients with longer disease duration are required to fully explore the potential of intermediate monocytes to drive bone loss in RA. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
26. Mild stimulatory effect of a probiotic mix on bone mass when treatment is initiated 1.5 weeks after ovariectomy in mice.
- Author
-
Ohlsson, Claes, Lawenius, Lina, Andersson, Annica, Gustafsson, Karin, Jianyao Wu, Lagerquist, Marie, Movérare-Skrtic, Sofia, Islander, Ulrika, and Sjögren, Klara
- Abstract
Studies in humans and rodents show that probiotic bacteria can protect from bone loss caused by sex steroid deficiency. We showed earlier that a mixture of three probiotic bacteria, Lacticaseibacillus paracasei DSM13434, Lactiplantibacillus plantarum DSM 15312, and DSM 15313 (L. mix), protects mice from ovariectomy (ovx)-induced bone loss when treatment was started 2 wk before sham and ovx surgery. In addition, the same probiotic treatment protected against lumbar spine bone loss in early postmenopausal women. In the present study, we wanted to evaluate the therapeutic potential of L. mix by starting treatment 1.5 wk after ovx when most of the rapid bone loss as a result of estrogen deficiency has already occurred. Treatment with L. mix for 5.5 wk increased the trabecular thickness but not the trabecular number in the proximal metaphyseal region of tibia compared with vehicle treatment. Cortical thickness and cortical area of the middiaphyseal part of the tibia were significantly decreased in ovx mice but not in L. mix-treated ovx mice. The bone-protective effects of L. mix in ovx mice were associated with a protection against ovx-induced reduction of the frequency of regulatory T-cells and of the expression of Tgfβ in the bone marrow. In conclusion, the probiotic L. mix exerted a mild stimulatory effect on trabecular and cortical bone width when treatment is initiated 1.5 wk after ovariectomy in mice. This effect was associated with effects on bone-protecting regulatory T-cells. The results suggest that L. mix may exert beneficial effects on bone mass when treatment is started after ovariectomy. NEW & NOTEWORTHY The probiotic L. mix exerted a mild stimulatory effect on trabecular and cortical bone width when treatment is initiated 1.5 wk after ovariectomy in mice. This effect was associated with effects on bone-protecting regulatory T-cells. The results suggest that L. mix may exert beneficial effects on bone mass when treatment is started after ovariectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
27. Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1*/* mice with collagen-induced chronic arthritis
- Author
-
Gjertsson Inger, Lagerquist Marie, Engdahl Cecilia, Erlandsson Malin, Islander Ulrika, Jochems Caroline, Ohlsson Claes, Holmdahl Rikard, and Carlsten Hans
- Subjects
Diseases of the musculoskeletal system ,RC925-935 - Abstract
Abstract Background Collagen-induced arthritis (CIA) is an often-used murine model for human rheumatoid arthritis (RA). Earlier studies have shown potent anti-arthritic effects with the female sex hormone estradiol and the selective estrogen receptor modulator (SERM) raloxifene in CIA in DBA/1-mice. B10.Q-ncf1*/*mice are B10.Q mice with a mutated Ncf1 gene. In B10.Q-ncf1*/*mice, CIA develops as a chronic relapsing disease, which more accurately mimics human RA. We investigated the role of endogenous and exogenous sex steroids and raloxifene in the course of this model of chronic arthritis. We also examined whether treatment would prevent the development of inflammation-triggered generalized osteoporosis. Methods Female B10.Q-ncf1*/*mice were sham-operated or ovariectomized, and CIA was induced. 22 days later, when 30% of the mice had developed arthritis, treatment with raloxifene, estradiol or vehicle was started, and the clinical disease was evaluated continuously. Treatment was continued until day 56 after immunization. At termination of the experiment (day 73), bone mineral density (BMD) was analyzed, paws were collected for histological examination, and sera were analyzed for markers of cartilage turnover and pro-inflammatory cytokines. Results Raloxifene and estradiol treatment, as well as endogenous estrogen, decreased the frequency of arthritis, prevented joint destruction and countered generalized osteoporosis. These effects were associated with lower serum levels of the pro-inflammatory cytokine IL-6. Conclusions This is the first study to show that raloxifene and estradiol can ameliorate established erosive arthritis and inflammation-triggered osteoporosis in this chronic arthritis model. We propose that treatment with raloxifene could be a beneficial addition to the treatment of postmenopausal RA.
- Published
- 2010
- Full Text
- View/download PDF
28. Phosphorylation site S122 in estrogen receptor α has a tissue‐dependent role in female mice.
- Author
-
Ohlsson, Claes, Gustafsson, Karin L., Farman, Helen H., Henning, Petra, Lionikaite, Vikte, Movérare‐Skrtic, Sofia, Sjögren, Klara, Törnqvist, Anna E., Andersson, Annica, Islander, Ulrika, Bernardi, Angelina I., Poutanen, Matti, Chambon, Pierre, and Lagerquist, Marie K.
- Published
- 2020
- Full Text
- View/download PDF
29. Type I interferon signaling in fibroblastic reticular cells prevents exhaustive activation of antiviral CD8+ T cells.
- Author
-
Perez-Shibayama, Christian, Islander, Ulrika, Lütge, Mechthild, Cheng, Hung-Wei, Onder, Lucas, Ring, Sandra S., De Martin, Angelina, Novkovic, Mario, Colston, Julia, Gil-Cruz, Cristina, and Ludewig, Burkhard
- Abstract
Stromal cells poised to defend: Fibroblastic reticular cells (FRCs) in lymph nodes help establish niches where productive cell interactions can engender effective immune defense. Perez-Shibayama et al. evaluated the contribution of type I interferons and interferon-stimulated genes to supporting normal FRC function by studying mice with conditional deletion of the type I interferon receptor (Ifnar) in FRCs. Single-cell RNA sequencing of Ifnar-deficient FRCs revealed baseline perturbations in FRC differentiation associated with changes in myeloid cell composition. Mice with Ifnar-deficient FRCs were compromised in their ability to control spread of a localized virus infection due, in part, to impaired CD8
+ T cells displaying features of exhaustive activation. Sensing of type I interferons by FRCs is critical to maintaining secondary lymphoid tissues in a poised state ready to repel viral infections. Fibroblastic reticular cells (FRCs) are stromal cells that actively promote the induction of immune responses by coordinating the interaction of innate and adaptive immune cells. However, whether and to which extent immune cell activation is determined by lymph node FRC reprogramming during acute viral infection has remained unexplored. Here, we genetically ablated expression of the type I interferon-α receptor (Ifnar) in Ccl19-Cre+ cells and found that sensing of type I interferon imprints an antiviral state in FRCs and thereby preserves myeloid cell composition in lymph nodes of naive mice. During localized lymphocytic choriomeningitis virus infection, IFNAR signaling precipitated profound phenotypic adaptation of all FRC subsets enhancing antigen presentation, chemokine-driven immune cell recruitment, and immune regulation. The IFNAR-dependent shift of all FRC subsets toward an immunostimulatory state reduced exhaustive CD8+ T cell activation. In sum, these results unveil intricate circuits underlying type I IFN sensing in lymph node FRCs that enable protective antiviral immunity. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
30. Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands
- Author
-
Gustafsson Jan-Åke, Lindberg Marie, Skrtic Sofia, Jochems Caroline, Erlandsson Malin C, Hasséus Bengt, Islander Ulrika, Ohlsson Claes, and Carlsten Hans
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Abstract
Abstract Background Estrogens and androgens have extensive effects on the immune system, for example they suppress both T and B lymphopoiesis in thymus and bone marrow. Submandibular glands are sexually dimorphic in rodents, resulting in larger granular convoluted tubules in males compared to females. The aim of the present experiments was to investigate the estrogenic and androgenic effects of 4-estren-3α,17β-diol (estren) on thymus, bone marrow and submandibular glands, and compare the effects to those of 17β-estradiol (E2) and 5α-dihydrotestosterone (DHT), respectively. Estrogen receptors (ERs) were blocked by treatment of mice with the ER-antagonist ICI 182,780; also, knock-out mice lacking one or both ERs were used. Results As expected, the presence of functional ERs was mandatory for all the effects of E2. Similar to DHT-treatment, estren-treatment resulted in decreased thymus weight, as well as decreased frequency of bone marrow B cells. Treatment with estren or DHT also resulted in a shift in submandibular glands towards an androgen phenotype. All the effects of estren and DHT were independent of ERs. Conclusion Our study is the first to show that estren has similar effects as the androgen DHT on lymphopoiesis in thymus and bone marrow, and on submandibular glands, and that these effects are independent of estrogen receptors. This supports the hypothesis of estren being able to signal through the androgen receptor.
- Published
- 2005
- Full Text
- View/download PDF
31. Pasteurized Akkermansia muciniphila protects from fat mass gain but not from bone loss.
- Author
-
Lawenius, Lina, Scheffler, Julia M., Gustafsson, Karin L., Henning, Petra, Nilsson, Karin H., Colldén, Hannah, Islander, Ulrika, Plovier, Hubert, Cani, Patrice D., de Vos, Willem M., Ohlsson, Claes, and Sjögren, Klara
- Subjects
BONES ,BONE resorption ,SUPPRESSOR cells ,COMPACT bone ,BONE growth ,CANCELLOUS bone - Abstract
Probiotic bacteria can protect from ovariectomy (ovx)-induced bone loss in mice. Akkermansia muciniphila is considered to have probiotic potential due to its beneficial effect on obesity and insulin resistance. The purpose of the present study was to determine if treatment with pasteurized Akkermansia muciniphila (pAkk) could prevent ovx-induced bone loss. Mice were treated with vehicle or pAkk for 4 wk, starting 3 days before ovx or sham surgery. Treatment with pAkk reduced fat mass accumulation confirming earlier findings. However, treatment with pAkk decreased trabecular and cortical bone mass in femur and vertebra of gonadal intact mice and did not protect from ovx-induced bone loss. Treatment with pAkk increased serum parathyroid hormone (PTH) levels and increased expression of the calcium transporter Trpv5 in kidney suggesting increased reabsorption of calcium in the kidneys. Serum amyloid A 3 (SAA3) can suppress bone formation and mediate the effects of PTH on bone resorption and bone loss in mice and treatment with pAkk increased serum levels of SAA3 and gene expression of Saa3 in colon. Moreover, regulatory T cells can be protective of bone and pAkk-treated mice had decreased number of regulatory T cells in mesenteric lymph nodes and bone marrow. In conclusion, treatment with pAkk protected from ovx-induced fat mass gain but not from bone loss and reduced bone mass in gonadal intact mice. Our findings with pAkk differ from some probiotics that have been shown to protect bone mass, demonstrating that not all prebiotic and probiotic factors have the same effect on bone. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
32. Roles of activating functions 1 and 2 of estrogen receptor α in lymphopoiesis.
- Author
-
Andersson, Annica, Törnqvist, Anna E., Moverare-Skrtic, Sofia, Bernardi, Angelina I., Farman, Helen H., Chambon, Pierre, Engdahl, Cecilia, Lagerquist, Marie K., Windahl, Sara H., Carlsten, Hans, Ohlsson, Claes, and Islander, Ulrika
- Subjects
ESTROGEN receptors ,SEX hormones ,IMMUNOREGULATION ,ESTRADIOL ,IMMUNOLOGICAL adjuvants ,FLOW cytometry - Abstract
Apart from the role of sex steroids in reproduction, sex steroids are also important regulators of the immune system. 17β-estradiol (E2) represses T and B cell development, but augments B cell function, possibly explaining the different nature of immune responses in men and women. Both E2 and selective estrogen receptors modulators (SERM) act via estrogen receptors (ER). Activating functions (AF)-1 and 2 of the ER bind to coregulators and thus influence target gene transcription and subsequent cellular response to ER activation. The importance of ERαAF-1 and AF-2 in the immunomodulatory effects of E2/SERM has previously not been reported. Thus, detailed studies of T and B lymphopoiesis were performed in ovariectomized E2-, lasofoxifeneor raloxifene-treated mice lacking either AF-1 or AF-2 domains of ERα, and their wildtype littermate controls. Immune cell phenotypes were analyzed with flow cytometry. All E2 and SERM-mediated inhibitory effects on thymus cellularity and thymic T cell development were clearly dependent on both ERαAFs. Interestingly, divergent roles of ERαAF-1 and ERαAF-2 in E2 and SERM-mediated modulation of bone marrow B lymphopoiesis were found. In contrast to E2, effects of lasofoxifene on early B cells did not require functional ERαAF-2, while ERαAF-1 was indispensable. Raloxifene reduced early B cells partly independent of both ERαAF-1 and ERαAF-2. Results from this study increase the understanding of the impact of ER modulation on the immune system, which can be useful in the clarification of the molecular actions of SERMs and in the development of new SERM. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
33. Immunomodulation by estrogen and estren
- Author
-
Islander, Ulrika
- Subjects
B cells ,inflammation ,estrogen receptor knock-out mice ,estren ,estrogen ,T cells ,lymphopoiesis ,immunoglobulin ,estrogen receptor - Abstract
Estrogen affects the development and regulation of the immune system. Treatment of gonadectomized mice with estrogen results in suppression of T and B lymphopoiesis, as well as decreased delayed type hypersensitivity reaction, granulocyte mediated inflammation and levels of IL-6 in serum. Conversely, immunoglobulin production is stimulated by estrogen. The effects of estrogen are mediated through the estrogen receptors (ER), ERa and ERb, which are ligand activated transcription factors that induce expression of specific estrogen responsive genes. The aims of this thesis were to investigate the role of ERs on B lymphopoiesis and immunoglobulin production, as well as on the aged immune system. Furthermore, the ER specific effects of the synthetic molecule estren on T and B lymphopoiesis, T cell-mediated inflammation and submandibular glands were studied. ER knock-out mice lacking ERa, ERb or both ERa and ERb, were gonadectomized and treated with 17b-estradiol-3-benzoate (E2) or 4-estren-3a,17b-diol (estren). We found that both ERa and ERb are required for the estrogen-induced decreased frequency of B lymphopoietic cells in the bone marrow. ERa alone is necessary for the estrogen-mediated, as well as for the age-induced, increased frequency of immunoglobulin producing B cells. We could also show that estren inhibits inflammation through ER-mediated pathways, while the inhibitory effects on T and B lymphopoiesis are not dependent on ERs. Furthermore, estren promotes an androgen phenotype in submandibular glands that is independent of ERs. In conclusion, our results show that the effects of estrogen on the immune system are mainly mediated via ERa, but signalling through ERb is necessary for complete inhibitory effect on B lymphopoiesis. Furthermore, estren treatment induces effects on lymphopoiesis and submandibular glands that are not mediated through ERs, but instead possibly through the androgen receptor.
- Published
- 2007
34. Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.
- Author
-
Stubelius, Alexandra, Andersson, Annica, Holmdahl, Rikard, Ohlsson, Claes, Islander, Ulrika, and Carlsten, Hans
- Subjects
OSTEOPOROSIS in women ,OSTEOCLASTS ,NADPH oxidase ,BONE density ,REACTIVE oxygen species - Abstract
Background: Increased reactive oxygen species and estrogen deficiency contribute to the pathophysiology of postmenopausal osteoporosis. Reactive oxygen species contribute to bone degradation and is necessary for RANKLinduced osteoclast differentiation. In postmenopausal bone loss, reactive oxygen species can also activate immune cells to further enhance bone resorption. Here, we investigated the role of reactive oxygen species in ovariectomyinduced osteoporosis in mice deficient in Ncf1, a subunit for the NADPH oxidase 2 and a well-known regulator of the immune system. Methods: B10.Q wild-type (WT) mice and mice with a spontaneous point mutation in the Ncf1-gene (Ncf1*/*) were ovariectomized (ovx) or sham-operated. After 4 weeks, osteoclasts were generated ex vivo, and bone mineral density was measured using peripheral quantitative computed tomography. Lymphocyte populations, macrophages, pre-osteoclasts and intracellular reactive oxygen species were analyzed by flow cytometry. Results: After ovx, Ncf1*/*-mice formed fewer osteoclasts ex vivo compared to WT mice. However, trabecular bone mineral density decreased similarly in both genotypes after ovx. Ncf1*/*-mice had a larger population of preosteoclasts, whereas lymphocytes were activated to the same extent in both genotypes. Conclusion: Ncf1*/*-mice develop fewer osteoclasts after ovx than WT mice. However, irrespective of genotype, bone mineral density decreases after ovx, indicating that a compensatory mechanism retains bone degradation after ovx. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
35. Trabecular bone loss in collagen antibody-induced arthritis.
- Author
-
Grahnemo, Louise, Andersson, Annica, Nurkkala-Karlsson, Merja, Stubelius, Alexandra, Lagerquist, Marie K., Svensson, Mattias N. D., Ohlsson, Claes, Carlsten, Hans, and Islander, Ulrika
- Published
- 2015
- Full Text
- View/download PDF
36. Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis.
- Author
-
Andersson, Annica, Stubelius, Alexandra, Karlsson, Merja Nurkkala, Engdahl, Cecilia, Erlandsson, Malin, Grahnemo, Louise, Lagerquist, Marie K., and Islander, Ulrika
- Published
- 2015
- Full Text
- View/download PDF
37. Effects of lasofoxifene and bazedoxifene on B cell development and function.
- Author
-
Bernardi, Angelina I., Andersson, Annica, Grahnemo, Louise, Nurkkala‐Karlsson, Merja, Ohlsson, Claes, Carlsten, Hans, and Islander, Ulrika
- Subjects
B cells ,OSTEOPOROSIS in women ,IMMUNITY ,IMMUNE response ,BONE density ,LABORATORY mice ,FLOW cytometry - Abstract
The third generation selective estrogen receptor modulators lasofoxifene (las) and bazedoxifene (bza) are indicated for treatment of postmenopausal osteoporosis. 17β-Estradiol (E2) and the second generation SERM raloxifene (ral) have major effects on the immune system, particularly on B cells. Treatment with E2 or ral inhibits B lymphopoiesis and treatment with E2, but not ral, stimulates antibody production. The effects of las and bza on the immune system have not been studied. Therefore, the aim of this study was to investigate their role in B cell development, maturation, and function. C57BL/6 mice were sham-operated or ovariectomized (ovx) and treated with vehicle, E2, ral, las, or bza. All substances increased total bone mineral density in ovx mice, as measured by peripheral quantitative computed tomography. In uterus, bza alone lacked agonistic effect in ovx mice and even acted as an antagonist in sham mice. As expected, E2 decreased B cell numbers at all developmental stages from pre-BI cells (in bone marrow) to transitional 1 (T1) B cells (in spleen) and increased marginal zone (MZ) B cells as determined by flow cytometry. However, treatment with las or bza only decreased the last stages of bone marrow B cell development and splenic T1 B cells, but had no effect MZ B cells. E2 increased antibody-producing cells quantified by ELISPOT, but las or bza did not. In conclusion, las and bza differ from E2 by retaining normal number of cells at most B cell stages during B lymphopoiesis and maturation and by not increasing antibody-producing cells. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
38. The role of total and cartilage-specific estrogen receptor alpha expression for the ameliorating effect of estrogen treatment on arthritis.
- Author
-
Engdahl, Cecilia, Börjesson, Anna E., Forsman, Huamei F., Andersson, Annica, Stubelius, Alexandra, Krust, Andree, Chambon, Pierre, Islander, Ulrika, Ohlsson, Claes, Carlsten, Hans, and Lagerquist, Marie K.
- Published
- 2014
- Full Text
- View/download PDF
39. Probiotics Protect Mice from Ovariectomy-Induced Cortical Bone Loss.
- Author
-
Ohlsson, Claes, Engdahl, Cecilia, Fåk, Frida, Andersson, Annica, Windahl, Sara H., Farman, Helen H., Movérare-Skrtic, Sofia, Islander, Ulrika, and Sjögren, Klara
- Subjects
PROBIOTICS ,OVARIECTOMY ,COMPACT bone ,OSTEOPOROSIS ,GUT microbiome ,LABORATORY mice - Abstract
The gut microbiota (GM) modulates the hosts metabolism and immune system. Probiotic bacteria are defined as live microorganisms which when administered in adequate amounts confer a health benefit on the host and can alter the composition of the GM. Germ-free mice have increased bone mass associated with reduced bone resorption indicating that the GM also regulates bone mass. Ovariectomy (ovx) results in bone loss associated with altered immune status. The purpose of this study was to determine if probiotic treatment protects mice from ovx-induced bone loss. Mice were treated with either a single Lactobacillus (L) strain, L. paracasei DSM13434 (L. para) or a mixture of three strains, L. paracasei DSM13434, L. plantarum DSM 15312 and DSM 15313 (L. mix) given in the drinking water during 6 weeks, starting two weeks before ovx. Both the L. para and the L. mix treatment protected mice from ovx-induced cortical bone loss and bone resorption. Cortical bone mineral content was higher in both L. para and L. mix treated ovx mice compared to vehicle (veh) treated ovx mice. Serum levels of the resorption marker C-terminal telopeptides and the urinary fractional excretion of calcium were increased by ovx in the veh treated but not in the L. para or the L. mix treated mice. Probiotic treatment reduced the expression of the two inflammatory cytokines, TNFα and IL-1β, and increased the expression of OPG, a potent inhibitor of osteoclastogenesis, in cortical bone of ovx mice. In addition, ovx decreased the frequency of regulatory T cells in bone marrow of veh treated but not probiotic treated mice. In conclusion, treatment with L. para or the L. mix prevents ovx-induced cortical bone loss. Our findings indicate that these probiotic treatments alter the immune status in bone resulting in attenuated bone resorption in ovx mice. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
40. The role of activation functions 1 and 2 of estrogen receptor-α for the effects of estradiol and selective estrogen receptor modulators in male mice.
- Author
-
Börjesson, Anna E, Farman, Helen H, Engdahl, Cecilia, Koskela, Antti, Sjögren, Klara, Kindblom, Jenny M, Stubelius, Alexandra, Islander, Ulrika, Carlsten, Hans, Antal, Maria Cristina, Krust, Andrée, Chambon, Pierre, Tuukkanen, Juha, Lagerquist, Marie K, Windahl, Sara H, and Ohlsson, Claes
- Abstract
Estradiol (E2) is important for male skeletal health and the effect of E2 is mediated via estrogen receptor (ER)-α. This was demonstrated by the findings that men with an inactivating mutation in aromatase or a nonfunctional ERα had osteopenia and continued longitudinal growth after sexual maturation. The aim of the present study was to evaluate the role of different domains of ERα for the effects of E2 and selective estrogen receptor modulators (SERMs) on bone mass in males. Three mouse models lacking either ERαAF-1 (ERαAF-1
0 ), ERαAF-2 (ERαAF-20 ), or the total ERα (ERα−/− ) were orchidectomized (orx) and treated with E2 or placebo. E2 treatment increased the trabecular and cortical bone mass and bone strength, whereas it reduced the thymus weight and bone marrow cellularity in orx wild type (WT) mice. These parameters did not respond to E2 treatment in orx ERα−/− or ERαAF-20 mirx ERαAF-10 mice were tissue-dependent, with a clear response in cortical bone parameters and bone marrow cellularity, but no response in trabecular bone. To determine the role of ERαAF-1 for the effects of SERMs, we treated orx WT and ERαAF-10 mice with raloxifene (Ral), lasofoxifene (Las), bazedoxifene (Bza), or vehicle. These SERMs increased total body areal bone mineral density (BMD) and trabecular volumetric BMD to a similar extent in orx WT mice. Furthermore, only Las increased cortical thickness significantly and only Bza increased bone strength significantly. However, all SERMs showed a tendency toward increased cortical bone parameters. Importantly, all SERM effects were absent in the orx ERαAF-10 mice. In conclusion, ERαAF-2 is required for the estrogenic effects on all evaluated parameters, whereas the role of ERαAF-1 is tissue-specific. All evaluated effects of Ral, Las and Bza are dependent on a functional ERαAF-1. Our findings might contribute to the development of bone-specific SERMs in males. © 2013 American Society for Bone and Mineral Research. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
41. Estrogens in rheumatoid arthritis; the immune system and bone
- Author
-
Islander, Ulrika, Jochems, Caroline, Lagerquist, Marie K., Forsblad-d’Elia, Helena, and Carlsten, Hans
- Subjects
- *
ESTROGEN , *RHEUMATOID arthritis , *IMMUNE system , *BONES , *AUTOIMMUNE diseases in women , *MENOPAUSE , *SEX hormones , *INFLAMMATION , *ARTHRITIS - Abstract
Abstract: Rheumatoid arthritis (RA) is an autoimmune disease that is more common in women than in men. The peak incidence in females coincides with menopause when the ovarian production of sex hormones drops markedly. RA is characterized by skeletal manifestations where production of pro-inflammatory mediators, connected to the inflammation in the joint, leads to bone loss. Animal studies have revealed distinct beneficial effects of estrogens on arthritis, and a positive effect of hormone replacement therapy has been reported in women with postmenopausal RA. This review will focus on the influence of female sex hormones in the pathogenesis and progression of RA. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
42. Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1*/* mice with collagen-induced chronic arthritis.
- Author
-
Jochems, Caroline, Islander, Ulrika, Erlandsson, Malin, Engdahl, Cecilia, Lagerquist, Marie, Gjertsson, Inger, Ohlsson, Claes, Holmdahl, Rikard, and Carlsten, Hans
- Subjects
- *
ARTHRITIS , *BONE diseases , *JOINT diseases , *OSTEOPOROSIS , *RHEUMATOID arthritis - Abstract
Background: Collagen-induced arthritis (CIA) is an often-used murine model for human rheumatoid arthritis (RA). Earlier studies have shown potent anti-arthritic effects with the female sex hormone estradiol and the selective estrogen receptor modulator (SERM) raloxifene in CIA in DBA/1-mice. B10.Q-ncf1*/*mice are B10.Q mice with a mutated Ncf1 gene. In B10.Q-ncf1*/*mice, CIA develops as a chronic relapsing disease, which more accurately mimics human RA. We investigated the role of endogenous and exogenous sex steroids and raloxifene in the course of this model of chronic arthritis. We also examined whether treatment would prevent the development of inflammation-triggered generalized osteoporosis. Methods: Female B10.Q-ncf1*/*mice were sham-operated or ovariectomized, and CIA was induced. 22 days later, when 30% of the mice had developed arthritis, treatment with raloxifene, estradiol or vehicle was started, and the clinical disease was evaluated continuously. Treatment was continued until day 56 after immunization. At termination of the experiment (day 73), bone mineral density (BMD) was analyzed, paws were collected for histological examination, and sera were analyzed for markers of cartilage turnover and pro-inflammatory cytokines. Results: Raloxifene and estradiol treatment, as well as endogenous estrogen, decreased the frequency of arthritis, prevented joint destruction and countered generalized osteoporosis. These effects were associated with lower serum levels of the pro-inflammatory cytokine IL-6. Conclusions: This is the first study to show that raloxifene and estradiol can ameliorate established erosive arthritis and inflammation-triggered osteoporosis in this chronic arthritis model. We propose that treatment with raloxifene could be a beneficial addition to the treatment of postmenopausal RA. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
43. Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands.
- Author
-
Islander, Ulrika, Hasséus, Bengt, Erlandsson, Malin C., Jochems, Caroline, Skrtic, Sofia Movérare, Lindberg, Marie, Gustafsson, Jan-Åke, Ohlsson, Claes, and Carlsten, Hans
- Subjects
- *
ESTROGEN , *ANDROGENS , *IMMUNE system , *THYMUS , *PHENOTYPES - Abstract
Background: Estrogens and androgens have extensive effects on the immune system, for example they suppress both T and B lymphopoiesis in thymus and bone marrow. Submandibular glands are sexually dimorphic in rodents, resulting in larger granular convoluted tubules in males compared to females. The aim of the present experiments was to investigate the estrogenic and androgenic effects of 4-estren-3 α ,17β-diol (estren) on thymus, bone marrow and submandibular glands, and compare the effects to those of 17β-estradiol (E2) and 5 α -dihydrotestosterone (DHT), respectively. Estrogen receptors (ERs) were blocked by treatment of mice with the ER-antagonist ICI 182,780; also, knock-out mice lacking one or both ERs were used. Results: As expected, the presence of functional ERs was mandatory for all the effects of E2. Similar to DHT-treatment, estren-treatment resulted in decreased thymus weight, as well as decreased frequency of bone marrow B cells. Treatment with estren or DHT also resulted in a shift in submandibular glands towards an androgen phenotype. All the effects of estren and DHT were independent of ERs. Conclusion: Our study is the first to show that estren has similar effects as the androgen DHT on lymphopoiesis in thymus and bone marrow, and on submandibular glands, and that these effects are independent of estrogen receptors. This supports the hypothesis of estren being able to signal through the androgen receptor. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
44. Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss
- Author
-
Stubelius, Alexandra, Andersson, Annica, Holmdahl, Rikard, Ohlsson, Claes, Islander, Ulrika, and Carlsten, Hans
- Subjects
Orthopedics and Sports Medicine - Full Text
- View/download PDF
45. Reply.
- Author
-
Forsman, Huamei, Islander, Ulrika, and Karlsson, Anna
- Subjects
- *
BREAST tumors , *HEART failure , *GENETICS of rheumatoid arthritis , *THYROID gland tumors , *GENETIC polymorphisms , *GENETICS - Abstract
A response by Huamei Forsman and colleagues is presented to a letter to the editor about their article "Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis" in the February 2011 issue.
- Published
- 2011
- Full Text
- View/download PDF
46. Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1*/* mice with collagen-induced chronic arthritis.
- Author
-
Jochems, Caroline, Islander, Ulrika, Erlandsson, Malin, Engdahl, Cecilia, Lagerquist, Marie, Gjertsson, Inger, Ohlsson, Claes, Holmdahl, Rikard, and Carlsten, Hans
- Abstract
Background: Collagen-induced arthritis (CIA) is an often-used murine model for human rheumatoid arthritis (RA). Earlier studies have shown potent anti-arthritic effects with the female sex hormone estradiol and the selective estrogen receptor modulator (SERM) raloxifene in CIA in DBA/1-mice. B10.Q-ncf1*/*mice are B10.Q mice with a mutated Ncf1 gene. In B10.Q-ncf1*/*mice, CIA develops as a chronic relapsing disease, which more accurately mimics human RA. We investigated the role of endogenous and exogenous sex steroids and raloxifene in the course of this model of chronic arthritis. We also examined whether treatment would prevent the development of inflammation-triggered generalized osteoporosis.Methods: Female B10.Q-ncf1*/*mice were sham-operated or ovariectomized, and CIA was induced. 22 days later, when 30% of the mice had developed arthritis, treatment with raloxifene, estradiol or vehicle was started, and the clinical disease was evaluated continuously. Treatment was continued until day 56 after immunization. At termination of the experiment (day 73), bone mineral density (BMD) was analyzed, paws were collected for histological examination, and sera were analyzed for markers of cartilage turnover and pro-inflammatory cytokines.Results: Raloxifene and estradiol treatment, as well as endogenous estrogen, decreased the frequency of arthritis, prevented joint destruction and countered generalized osteoporosis. These effects were associated with lower serum levels of the pro-inflammatory cytokine IL-6.Conclusions: This is the first study to show that raloxifene and estradiol can ameliorate established erosive arthritis and inflammation-triggered osteoporosis in this chronic arthritis model. We propose that treatment with raloxifene could be a beneficial addition to the treatment of postmenopausal RA. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
47. Immunomodulation by the estrogen metabolite 2-methoxyestradiol.
- Author
-
Stubelius, Alexandra, Erlandsson, Malin C., Islander, Ulrika, and Carlsten, Hans
- Subjects
- *
IMMUNOREGULATION , *ESTROGEN , *METABOLITES , *ESTRADIOL , *CLINICAL trials , *CANCER research , *INFLAMMATION , *LABORATORY mice - Abstract
Abstract: 2-methoxyestradiol (2me2), a metabolite of 17β-estradiol (E2), has been tested in phase II clinical cancer trials and models of inflammation. Its effects are only partly clarified. We investigated the effects of 2me2 on the immune system, using ovariectomized or sham-operated mice treated with a high and a low dose of 2me2 (2me2H and 2me2L), E2 or vehicle. We investigated antagonism of tissue proliferation and estrogen response element (ERE) activation. Established immunomodulation by E2 was reproduced. 2me2L increased NK and T-cells from bone marrow, spleen and liver. Both 2me2H and E2 induced uterus proliferation in ovariectomized mice, but no antagonistic effects on uteri growth were seen in intact animals. Both E2 and 2me2H activated EREs. Immunomodulation by 2me2 is tissue-, and concentration dependent. E2 regulated the immune system more potently. The higher dose of 2me2 resulted in E2 like effects, important to consider when developing 2me2 as a drug. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
48. Role of 2-methoxyestradiol as inhibitor of arthritis and osteoporosis in a model of postmenopausal rheumatoid arthritis
- Author
-
Stubelius, Alexandra, Andréasson, Emil, Karlsson, Anna, Ohlsson, Claes, Tivesten, Åsa, Islander, Ulrika, and Carlsten, Hans
- Subjects
- *
RHEUMATOID arthritis , *ESTRADIOL , *OSTEOPOROSIS , *DRUG administration , *REACTIVE oxygen species , *BONE density , *ESTROGEN receptors , *CHEMILUMINESCENCE - Abstract
Abstract: In postmenopausal rheumatoid arthritis, both the inflammatory disease and estrogen deficiency contribute to the development of osteoporosis. As hormone replacement therapy is no longer an option, we hypothesized that 2-methoxyestradiol (2me2) could be beneficial, and asked if such therapy was associated with effects on reproductive organs. Mice were ovariectomized and arthritis was induced, whereafter mice were administered 2me2, estradiol, or placebo. Clinical and histological scores of arthritis, together with bone mineral density were evaluated. Uteri weight, reactive oxygen species (ROS) from spleen cells, and characterization of cells from joints and lymph nodes were analyzed. In addition, in vivo activation of estrogen response elements (ERE) by 2me2 was evaluated. Treatment with 2me2 and estradiol decreased the frequency and severity of arthritis and preserved bone. Joint destruction was reduced, neutrophils diminished and ROS production decreased. The uterine weight increased upon long-term 2me2 exposure, however short-term exposure did not activate ERE in vivo. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
49. Pulsed administration for physiological estrogen replacement in mice.
- Author
-
Corciulo C, Scheffler JM, Gustafsson KL, Drevinge C, Humeniuk P, Del Carpio Pons AM, Poutanen M, Ohlsson C, Lagerquist MK, and Islander U
- Subjects
- Animals, Central Nervous System, Female, Hormone Replacement Therapy, Humans, Mice, Ovariectomy, Estrogen Replacement Therapy, Estrogens
- Abstract
Estrogens are important regulators of body physiology and have major effects on metabolism, bone, the immune- and central nervous systems. The specific mechanisms underlying the effects of estrogens on various cells, tissues and organs are unclear and mouse models constitute a powerful experimental tool to define the physiological and pathological properties of estrogens. Menopause can be mimicked in animal models by surgical removal of the ovaries and replacement therapy with 17β-estradiol in ovariectomized (OVX) mice is a common technique used to determine specific effects of the hormone. However, these studies are complicated by the non-monotonic dose-response of estradiol, when given as therapy. Increased knowledge of how to distribute estradiol in terms of solvent, dose, and administration frequency, is required in order to accurately mimic physiological conditions in studies where estradiol treatment is performed. In this study, mice were OVX and treated with physiological doses of 17β-estradiol-3-benzoate (E2) dissolved in miglyol or PBS. Subcutaneous injections were performed every 4 days to resemble the estrus cycle in mice. Results show that OVX induces an osteoporotic phenotype, fat accumulation and impairment of the locomotor ability, as expected. Pulsed administration of physiological doses of E2 dissolved in miglyol rescues the phenotypes induced by OVX. However, when E2 is dissolved in PBS the effects are less pronounced, possibly due to rapid wash out of the steroid., Competing Interests: No competing interests were disclosed., (Copyright: © 2021 Corciulo C et al.)
- Published
- 2021
- Full Text
- View/download PDF
50. Intermediate monocytes correlate with CXCR3+ Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis.
- Author
-
Drevinge C, Scheffler JM, Koro-Arvidsson C, Sundh D, Carlsten H, Gjertsson I, Lindholm C, Lorentzon M, Rudin A, Ekwall AH, and Islander U
- Subjects
- Humans, Female, Male, Middle Aged, Adult, Aged, Bone and Bones pathology, Bone and Bones diagnostic imaging, Case-Control Studies, Arthritis, Rheumatoid immunology, Arthritis, Rheumatoid pathology, Arthritis, Rheumatoid blood, Monocytes immunology, Monocytes pathology, Th17 Cells immunology, Th17 Cells metabolism, Bone Density, Receptors, CXCR3 metabolism
- Abstract
Background: Rheumatoid arthritis (RA) is associated with development of generalized osteoporosis. Bone-degrading osteoclasts are derived from circulating precursor cells of monocytic lineage, and the intermediate monocyte population is important as osteoclast precursors in inflammatory conditions. T cells of various subsets are critical in the pathogenesis of both RA and associated osteoporosis, but so far, no studies have examined associations between circulating intermediate monocytes, T cell subsets and bone characteristics in patients with RA. The aim of this study was to investigate the frequency of intermediate monocytes in patients with untreated early rheumatoid arthritis (ueRA) compared to healthy controls (HC), and to explore the correlation between intermediate monocytes and a comprehensive panel of T helper cell subsets, bone density and bone microarchitecture in ueRA patients., Methods: 78 patients with ueRA fulfilling the ACR/EULAR 2010 criteria were included and compared to 29 age- and sex-matched HC. Peripheral blood samples were obtained before start of treatment and proportions of monocyte subsets and CD4+ helper and regulatory T cell subsets were analyzed by flow cytometry. Bone densitometry was performed on 46 of the ueRA patients at inclusion using DXA and HR-pQCT., Results: Flow cytometric analyses showed that the majority of ueRA patients had frequencies of intermediate monocytes comparable to HC. The intermediate monocyte population correlated positively with CXCR3+ Th17 cells in ueRA patients but not in HC. However, neither the proportions of intermediate monocytes nor CXCR3+ Th17 cells were associated with bone density or bone microarchitecture measurements., Conclusions: Our findings suggest that in early RA, the intermediate monocytes do not correlate with bone characteristics, despite positive correlation with circulating CXCR3+ Th17 cells. Future longitudinal studies in patients with longer disease duration are required to fully explore the potential of intermediate monocytes to drive bone loss in RA., Competing Interests: Mattias Lorentzon has received lecture fees from Amgen, Gedeon Richter, Lilly, Meda, Renapharma, UCB Pharma, and consulting fees from Amgen, Radius Health, UCB Pharma, Renapharma and Consilient Health, all outside the presented work. This does not alter our adherence to PLOS ONE policies on sharing data and materials. None of the other authors have any conflict of interests related to this manuscript.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.